INTRODUCTION
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in the United States (1) . CRC most often arises in adenomatous polyps that form throughout the colon. The current model of colorectal tumorigenesis posits a stepwise accumulation of mutations in tumor suppressor genes, oncogenes, and genetic instability genes, giving rise to adenomatous polyps that progress to adenocarcinoma over a period of years (2, 3) .
However, only a small fraction of polyps progress to cancer. Observational studies have shown that over time colorectal polyps can grow, remain static in size, regress (or decrease in size), or resolve altogether (4) (5) (6) . Because of their malignant potential, polyps that are identified on screening colonoscopy are removed. Increased surveillance is recommended after polyps are found (7) , further straining a medical system that already struggles to meet the demand for screening and diagnostic colonoscopies, both in terms of cost (8) and available providers (9) . Additionally, colonoscopy and polypectomy are not without risk; colonic perforation occurs at a low but predictable rate during colonoscopy (10) , and significant post-colonoscopy bleeding is more likely to occur after polypectomy (11) .
Current efforts are focused on risk-stratifying patients with colorectal polyps. A potential method for quantifying risk for CRC would be to identify polyps that are more likely to grow and progress to cancer and those that are likely to be benign. Attempts have been made to predict polyp fate and carcinogenic potential using the size and number of polyps, as well as histologic features of removed polyps (7) . It is currently unknown if analysis of gene expression profiles from polyps can add further specificity to risk between normal colonic mucosa, adenomatous polyps, and CRC in humans (12) , as well as correlate gene expression profiles with colonoscopic findings (13) . However, the information gathered from gene expression profiles in human tumors is difficult to interpret functionally because of molecular heterogeneity in neoplastic tissue coupled with the genetic variability inherent in human populations.
Animal models can minimize genetic variation while allowing experimental manipulation of tumorigenesis. Our group has developed a long-lived mouse model with a germline truncating mutation in the mouse homolog of APC that forms adenomatous colonic polyps which can be monitored by serial colonoscopies (14, 15) . We previously showed that 24 to 87% of intestinal tumors in this model progress to adenocarcinoma, and 3% develop nodal metastases. These cancers develop without a high level of microsatellite instability or chromosomal gains or losses (15) . We have now extended our previous work by meticulously characterizing the natural history of colonic tumors in this model to determine whether colonic tumors have growth patterns similar to those of colonic polyps in humans. We observed five distinct growth patterns as well as benign and malignant pathology. We have also begun to characterize molecular features of tumors with different degrees of invasiveness in this model. identified by genotyping at Apc using a previously described polymerase chain reaction (PCR) assay (16) .
Dextran Sodium Sulfate Treatment
At or within one week of weaning (24-35 days of age), F1 Min mice were treated with dextran sodium sulfate (DSS, average M.W. 500,000; Fisher Scientific, Waltham, MA), to increase colonic tumor multiplicity. Mice were given a 4% solution of DSS dissolved in water ad libitum for four days, followed by 17 days of regular water, and then a second cycle of 4% DSS for four days (17) . After allowing 30 days for tumor initiation, the colonoscopic surveillance and biopsy protocols were begun (Supplementary Figure 1) . A total of 273 mice were enrolled in the surveillance protocol, but only 101 remained on this protocol until they became moribund. Note that 172 mice were randomly removed 8 from the surveillance protocol for various drug studies. Only images of colonic tumors that were collected prior to treatment were used to assess growth behavior. A total of 12 mice were enrolled in the biopsy protocol.
Surveillance Protocol
The distal four centimeters of the colon were visualized in 273 DSS-treated F1 Min mice by colonoscopy using the Karl Storz Coloview system as previously described (18) .
Briefly, mice were anesthetized using inhaled isoflurane. The distal colon was prepped using enemas of phosphate buffered solution (PBS) until clear of fecal pellets and debris.
Room air delivered by a compressed air pump through the operating sheath of the colonoscope was used to insufflate the colon. The colonoscope was inserted distally and advanced as far proximally as possible, typically until a sharp bend in the colon was encountered, and then slowly withdrawn. The colonic mucosa was inspected during withdrawal, and digital video of the mucosa was recorded. Still images were collected of any tumors as they were encountered. To standardize images for comparison of discrete tumors over time, the colon was maximally insufflated and the colonoscope was positioned so that the entire tumor could be seen with the base of the tumor just at the edge of the screen (demonstrated in Figure 1 ). Mice were monitored post-procedurally and allowed to recover from anesthesia. Mice underwent surveillance colonoscopy in session and rated by a single reviewer as growing, remaining static in size, regressing, resolved, prolapsing from the anus, or unable to assess. Tumor age was defined as the number of days since a tumor was first identified on colonoscopy.
Tumor Histology Assessment
When mice became moribund, they were sacrificed by CO 2 asphyxiation. The entire intestinal tract was removed, opened longitudinally and washed with PBS, fixed for 16 to 24 hours in 10% buffered formalin (Fisher Scientific, Waltham, MA), and stored in 70% ethanol. Using a stereomicroscope, the total number of tumors in the small intestine and colon was counted. A randomly selected representative sample of 54 small intestinal tumors from six mice and 30 colonic tumors from 16 mice that had been followed by surveillance colonoscopy were removed for histologic evaluation. These tumors were paraffin-embedded, cut into 5 μm sections, and hematoxylin-eosin (H&E) stained prior to assessment of tumor invasiveness by a veterinary pathologist.
Biopsy Protocol
The operating sheath housing the colonoscope possesses a working channel that allows passage of 3 French biopsy forceps, which is 5mm in size when fully opened. A cohort of 12 mice with tumors amenable to biopsy was identified at their first colonoscopy.
These tumors underwent biopsy when mice were approximately 90 days of age. 
Immunohistochemistry
Immunohistochemical analysis of the tumor biopsies was also performed using anti-β-catenin antibody (D10A8, Cell Signaling Technology; 19). Samples were fixed, embedded, and cut as described above. Antigen retrieval was performed using 10mM citrate buffer heated to boiling for 32 minutes and blocked for endogenous peroxidase 
RNA Purification
Samples were disrupted in RLT buffer with a Kontes Pellet Grinder (Kimple & Chase, Vineland, NJ). RNA was extracted using the RNEasy Micro Kit (Qiagen) following manufacturer's instructions. The Nanodrop DU-800 (Thermo Scientific, Waltham, MA) was used to quantify yield and assess purity.
Gene Expression Analysis
Affymetrix Mouse Gene 1.0 ST GeneChips (Affymetrix, Santa Clara, CA) were used for microarray analysis. Hybridization and scanning of the chips were performed by the Gene Expression Center at the University of Wisconsin Biotechnology Center according to standard Affymetrix protocol. Chips were normalized by robust multiarray averaging using the XPS system (20) . Following preliminary analyses involving per gene analysis of variance, differential expression between adenomas and intramucosal carcinomas was measured by Student's t-test and fold change. We screened by fold change exceeding 2 and by unadjusted p-value less than 0.05. The false discovery rate (FDR) in the reported gene list was determined by the q-value method (21), and could not be reduced below 51% given the sample size. Functional categories showing adenoma/intramucosal carcinoma differential expression were assessed by standardized average (over category) log fold changes, as computed in the R package allez (22) . We screened for categories with outlying Z scores relative to category size. 
Reverse transcription and qPCR
RNA quantification was performed on a Nano-Drop DU-800 (Thermo-Fisch). cDNA was generated by reverse transcription of 50ng of total RNA, which had been stored at -80°C, according to the manufacturer's recommendation (ImProm II Reverse Transcription System, Promega). cDNA was stored at -20°C. Control cDNA was generated from Mouse Total Colon RNA (Clontech).
Commercially available primer and hydrolysis probe sequences for Tnfsf10 Table 1 ).
Tumor Growth Patterns
Colonic tumors in F1 Min mice had five distinct growth patterns: growth, stasis, regression (tumor decreased in size but did not resolve), resolution, and prolapse, which were evident by comparing standardized images that were collected at different times 
1% of tumors 147 days old). Conversely, tumors that had been present longer and tended to be larger occluding half of the lumen or more were more likely to remain static in size (36% of 21 day old tumors versus 52% of tumors 147 days of age). The percentage of tumors that prolapsed also increased over time (3% of 21 day old tumors compared to 30% of 147 day old tumors). These lesions tended to be located near the anus. Tumor regression was seen at a low rate throughout the lifespan of the mice, ranging from 1% to 6% at various time points (Figure 1 Panel D) . Thus, the growth patterns of tumors varied with the age of the tumor.
Tumor Pathology
A subset of randomly selected small intestinal and colonic tumors from mice in the surveillance protocol cohort underwent histologic evaluation. Fifty-four small intestinal tumors were collected from six DSS-treated F1 Min mice and were analyzed by an experienced veterinary pathologist to assess tumor invasiveness. The six mice had a mean age at death of 280 days (range 185-326 days). Thirty-one tumors were adenomas (57%), 10 were intramucosal carcinomas (19%), and 13 were adenocarcinomas (24%). 
Serial Biopsies of Tumors
Twelve mice, six males and six females, with distal colon tumors identified on initial colonoscopy at approximately 80 days of age underwent serial biopsies of tumors every 28 days until moribund as described above (Supplementary Figure 1B) . These same biopsies were analyzed for changes in gene expression that occurred over time. There was no significant differential gene expression between early and late biopsies. However, a modest differential expression was detected between adenomas and intramucosal carcinomas, regardless of whether the biopsies were from an early or late time point (Supplementary Figure 2) . We report a list of 68 genes exhibiting differential expression between adenomas and intramucosal carcinomas (Supplementary Table 2 ).
Of note, Resistin-like beta (Retnlb or REMLβ), Mucin 2 (Muc2), and Intestinal trefoil factor 3 (Tff3) were expressed at a higher level in adenomas relative to intramucosal carcinoma, whereas Tumor necrosis factor (ligand) superfamily, member 10 (Tnfsf10) and Lipocalin 2 (Lcn2) were overexpressed in intramucosal carcinoma relative to adenomas (Table 1 ). These differences were confirmed by quantitative PCR in all cases, except Tnfsf10 for which the difference was trending in the same direction as observed by microarray, but it was not quite statistically significant. In addition to these, a number of genes related to immune function and cell adhesion were differentially expressed, which may have an impact on the invasive and metastatic potential of these tumors (Supplementary Table 2 ). Although these 68 genes showed the strongest differential expression within this data set, the gene-level p-values are not FDR corrected. While we report genes with at least a 2-fold change in expression level and an unadjusted p-value ≤0.05, because of the FDR, we can predict that about half of these genes will not be validated on quantitative studies. In addition, functional categories in gene ontology showing adenoma/intramucosal carcinoma differential expression were examined (Supplementary Table 3 
20
progress to cancer in humans (23) and because polyps are removed when found on colonoscopy, longitudinal studies to understand the interactions between the host and the tumor are prohibitively difficult. Our murine model mirrors the growth patterns seen in human colorectal polyps, making it a valuable tool for discovering methods of riskstratifying colonic tumors, as colonic tumors in these animals can be followed with serial biopsies to assess changes within tumors over time.
Newly developed tumors were more likely to grow or resolve, while more established tumors, which remain fairly static in size, seemed to have reached a level of accommodation with the organism. This model could be used to examine factors intrinsic to the host organism which impact polyp growth, such as host immune responses to tumors and the inflammatory response to premalignant lesions. A number of genes related to immune function and increased T-cell activity were relatively overexpressed in intramucosal carcinomas relative to adenomas (Table 1, Supplementary Table 2) , indicating that this model may be useful for investigating the interplay between tumor and host immune system. Being able to predict which tumors will be contained by the host and remain static or regress spontaneously and which will break free of host constraints to continue to grow and progress to cancer would be invaluable both for understanding the natural history of CRC as well as risk-stratifying patients.
While we have presented an extensive characterization of the growth patterns and histology of colonic tumors in DSS-treated F1 Min mice, we have only preliminarily begun to describe molecular and genetic characteristics of these tumors. In this small sample, we did not find differentially expressed genes between early and late biopsies of 
tumors followed longitudinally. If these tumors progress along the same adenomacarcinoma sequence that has been described in human colonic tumors, we might have expected to see changes in gene expression over time. However, this was not observed.
This may be related to the dynamics of tumor progression in this animal model, but could also be explained by the small sample size. Alternatively, this may be a manifestation of cancer predetermination; by the time colonic tumors are large enough to be detected, they have already acquired mutations that will cause them to become invasive (24) .
We did identify a number of differentially expressed genes that have been linked to 
